Olympus opts for Munich site for life sciences R&D (research and development) centre:
This article was originally published in Clinica
Japanese camera and medical products developer Olympus has opted to locate its new life science research and development centre in Munich, Germany. Tokyo-based Olympus will invest some Euro15m ($21m) in the project, which will be opened officially in October. By 2009, it will be employing a staff of 450, who will be involved in production as well as R&D in the fields of molecular diagnostics, laboratory automation and digital processing in microscopy. Olympus' regional HQ, Olympus Europa Holding, is located in Hamburg. The proximity of the University Hospital Grosshadern to the new Bavarian site was an advantage, said Olympus regional executive managing director Dr Helmut Kohler. The group will be working in close co-operation with the hospital.
You may also be interested in...
Oncology Center of Excellence is reviewing a research report on fluorouracil, and will next look to update cisplatin's label, but eventually must convince the reference product sponsor to submit the changes.
US FDA’s ‘Project Renewal’ requires lots of work and flexibility, Oncology Center of Excellence acknowledges. Side-benefit may be getting outside physicians to appreciate the value of drug labeling.
The pharmaceutical industry would lose bid to eliminate PUPSIT but win relaxed WFI in proposed EU GMP Annex I revision.